Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D051379:Mice
D001549:Benzamides; D015102:3,4-Dihydroxyphenylacetic Acid; D001285:Atropine; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid